Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jan Kostun"'
Autor:
Lenka Kasikova, Michal Hensler, Iva Truxova, Petr Skapa, Jan Laco, Lucie Belicova, Ivan Praznovec, Sarka Vosahlikova, Michael J. Halaska, Tomas Brtnicky, Lukas Rob, Jiri Presl, Jan Kostun, Isabelle Cremer, Ales Ryska, Guido Kroemer, Lorenzo Galluzzi, Radek Spisek, Jitka Fucikova
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-12 (2019)
Abstract Background Adjuvanticity, which is the ability of neoplastic cells to deliver danger signals, is critical for the host immune system to mount spontaneous and therapy-driven anticancer immune responses. One of such signals, i.e., the exposure
Externí odkaz:
https://doaj.org/article/dd34c6ab408e4a95a1f9593ae45f4fa1
Publikováno v:
ePoster.
Introduction/Background Lymph node (LN) status is one of the most important prognostic factors in gynecologic cancer. Moreover, in patients with cervical and vulvar cancer, intraoperative LN assessment is important for relevant decision-making regard
Autor:
Jan Kostun, J Bouda, H Sidlova, K Cerna, Ondrej Ondič, Pavel Vlasák, I Kinkorova-Lunackova, Barbora Gomolčáková, Jiří Presl, Reza Alaghehbandan, O Majek, J Nemcova, Jan Chytra
Publikováno v:
ePoster.
Introduction/Background Methylation silencing of tumor suppressor genes has been suggested as one of the epigenetic changes promoting carcinogenesis. The aim of this study was to prospectively evaluate methylation status of CADM 1, MAL, hsa-miR-124 g
Publikováno v:
Journal of Obstetrics and Gynaecology. 38:110-114
The aim of our study was to clarify whether the CD44 adhesion molecule as a cancer stem cell marker could also serve as a prognostic factor in patients with epithelial ovarian cancer (EOC). A retrospective study was performed on 87 patients with hist
Autor:
Pavel Vlasák, Jiri Bouda, Zdenek Novotny, Markéta Bednaříková, Petra Ovesná, Jiří Presl, Vít Weinberger, Ondřej Topolčan, Jan Kostun, Radek Kucera
Publikováno v:
Anticancer Research. 37:2697-2702
Aim: To analyze the utility of HE4 assessment in preoperative management of patients with early-stage endometrial cancer for stratification into low-risk and high-risk groups. Patients and Methods: The following data were prospectively collected from